CAS: 1260612-13-2
4(3H)-Pyrimidinone, 2-[2-[(2S)-2,3-dihydro-2-methyl-1H-indol-1-yl]-2-oxoethyl]-6-(4-morpholinyl)-
CAS:1260612-13-2
Formula:
C19H22N4O3
Purity:
98%
Molecular weight:
354.4030
Ref: AN-AG000QW8
1mg | To inquire | |
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire | |
500mg | To inquire |
Estimated delivery in United States, on Thursday 2 May 2024
SAR-260301
CAS:1260612-13-2
SAR-260301 is an orally available and selective inhibitor of PI3Kβ (IC50: 23 nM).
Formula:
C19H22N4O3
Purity:
98.65%
Color and Shape:
Solid
Molecular weight:
354.4
Ref: TM-T16841
1mg | 52.00 € | |
5mg | 101.00 € | |
10mg | 177.00 € | |
25mg | 368.00 € | |
50mg | 552.00 € | |
100mg | 785.00 € | |
500mg | 1,606.00 € | |
1ml*10 (DMSO) | 112.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
(S)-2-(2-(2-Methylindolin-1-yl)-2-oxoethyl)-6-morpholinopyrimidin-4(3H)-one
CAS:1260612-13-2
Purity:
95.0%
Molecular weight:
354.4100036621094
Ref: 10-F497230
1g | To inquire | |
250mg | To inquire |
Estimated delivery in United States, on Tuesday 14 May 2024
SAR-260301
CAS:1260612-13-2
SAR-260301 is a small molecule that inhibits the activation of epidermal growth factor receptor (EGFR), …
Formula:
C19H22N4O3
Purity:
Min. 95%
Molecular weight:
354.4 g/mol
Ref: 3D-KAC61213
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Thursday 13 Jun 2024